These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6370148

  • 1. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P, Repo H, Leirisalo M, Kiistala U, Osterman T, Vapaatalo H.
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [Abstract] [Full Text] [Related]

  • 2. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H, Koivuranta-Vaara P, Leirisalo-Repo M.
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [Abstract] [Full Text] [Related]

  • 3. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H, Leirisalo M, Tiilikainen A, Laitinen O.
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [Abstract] [Full Text] [Related]

  • 4. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
    Leirisalo M, Repo H, Tiilikainen A, Kosunen TU, Laitinen O.
    Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
    [Abstract] [Full Text] [Related]

  • 5. Yersinia arthritis, immune functions and histocompatibility antigens.
    Repo H, Leirisalo-Repo M, Gripenberg M, Koskimies S, Kontiainen S, Laitinen O.
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
    [Abstract] [Full Text] [Related]

  • 6. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro.
    Repo H, Leirisalo-Repo M, Koskimies S.
    Clin Exp Rheumatol; 1988 Dec; 6(3):227-31. PubMed ID: 3263238
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neutrophil function and HLA-B27.
    Repo H, Leirisalo M, Koivuranta P, Osterman T, Kiistala U, Gahmberg CG, Vapaatalo H, Tiilikainen A, Laitinen O.
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):168-71. PubMed ID: 6606470
    [Abstract] [Full Text] [Related]

  • 9. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H, Jäättelä M, Leirisalo-Repo M, Hurme M.
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [Abstract] [Full Text] [Related]

  • 10. Complement activation and HLA-B27.
    Meri S, Partanen J, Leirisalo-Repo M, Repo H.
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [Abstract] [Full Text] [Related]

  • 11. Exaggerated inflammatory responsiveness plays a part in the pathogenesis of HLA-B27 linked diseases--hypothesis.
    Repo H, Leirisalo-Repo M, Koivuranta-Vaara P.
    Ann Clin Res; 1984 Mar; 16(1):47-50. PubMed ID: 6378047
    [Abstract] [Full Text] [Related]

  • 12. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.
    Repo H, Leirisalo-Repo M, Skurnik M, Tiilikainen A.
    Med Biol; 1984 Mar; 62(2):91-4. PubMed ID: 6088912
    [Abstract] [Full Text] [Related]

  • 13. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O, Leirisalo M, Skylv G.
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [Abstract] [Full Text] [Related]

  • 14. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
    Bucknall R, Leirisalo-Repo M, Laitinen O, Jones JV.
    Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M, Laitinen O, Tiilikainen A.
    J Rheumatol Suppl; 1977 Dec; 3():78-83. PubMed ID: 266605
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Signalling profiles of circulating leucocytes in patients recovered from reactive arthritis.
    Alanärä T, Aittomäki S, Kuuliala K, Kuuliala A, Siitonen S, Leirisalo-Repo M, Repo H.
    Scand J Rheumatol; 2012 Aug; 41(4):267-74. PubMed ID: 22651550
    [Abstract] [Full Text] [Related]

  • 20. Immune responses in yersinia-associated reactive arthritis.
    Aho K, Ahvonen P, Juvakoski T, Kousa M, Leirisalo M, Laitinen O.
    Ann Rheum Dis; 1979 Aug; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.